Please Wait...

Bone TRAP // Bone Tartrate Resistant Acid Phosphatase

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Tartrate-resistant acid phosphatase produced in bone-resorbing osteoclasts (TRACP 5b), or Bone Trap, is one of the two isoforms of TRACP (Janckila et al., 2003). The two isoforms differ in their content in sialic acid and TRACP 5a has a reduced activity at pH 6.0 (Halleen et al., 2000; Nenonen et al., 2005). Variation in serum levels of TRACP 5b isoform reflects modification in the bone resorption rate (Halleen et al., 2001).

Bioclinica Lab employs an immune-fixed enzyme activity assay designed to measure specific activity of TRACP 5b activity in human serum. To differentiate the two isoforms, the immunoassay used in the laboratory is a pH selective activity assay.

ADDITIONAL RESOURCES

Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Today at #SCDM2018 be sure to catch the Technology Ignite session @SCDM_DataDriven where @bioclinica's Clean Patien… https://t.co/HPs0hrLWwO
bioclinica (3 hours ago)
RT @eClinical_Jen: Data Management times are a’changing! AI, Machine Learning, Blockchain, IoT. Leadership Forum at @SCDM_DataDriven #scdm2…
bioclinica (3 hours ago)
RT @virtue_insight: #VIphv We are delighted to announce our new Gold Sponsor @bioclinica for our 16th Pharmacovigilance 2018 https://t.co/h…
bioclinica (5 days ago)
RT @bioclinica: Tackling the costly issue of drug supply waste in clinical trials. Find out how Novo Nordisk & other global pharmas R embra…
bioclinica (5 days ago)
Tackling the costly issue of drug supply waste in clinical trials. Find out how Novo Nordisk & other global pharmas… https://t.co/iW7Q9DfVgQ
bioclinica (2 weeks ago)
Background & key considerations to help #pharma prepare for new FDA blood pressure draft guidance issued in May. Ac… https://t.co/07dJeeD35E
bioclinica (3 weeks ago)

Latest Blogs:

Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations